Curaleaf Holdings Management
Management criteria checks 2/4
Curaleaf Holdings' CEO is Boris Jordan, appointed in Aug 2024, has a tenure of less than a year. total yearly compensation is $12.35M, comprised of 6.1% salary and 93.9% bonuses, including company stock and options. directly owns 17.37% of the company’s shares, worth CA$533.83M. The average tenure of the management team and the board of directors is 2.3 years and 5.4 years respectively.
Key information
Boris Jordan
Chief executive officer
US$12.4m
Total compensation
CEO salary percentage | 6.1% |
CEO tenure | less than a year |
CEO ownership | 17.4% |
Management average tenure | 2.3yrs |
Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Aug 13These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively
Jul 19Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%
Jun 14Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%
Jan 19Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?
Dec 11Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?
Sep 08Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?
May 28We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt
Sep 05Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden
May 20Is Curaleaf Holdings (CSE:CURA) A Risky Investment?
Oct 26Loss-Making Curaleaf Holdings, Inc. (CSE:CURA) Set To Breakeven
Mar 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$221m |
Mar 31 2024 | n/a | n/a | -US$237m |
Dec 31 2023 | US$12m | US$750k | -US$230m |
Sep 30 2023 | n/a | n/a | -US$349m |
Jun 30 2023 | n/a | n/a | -US$318m |
Mar 31 2023 | n/a | n/a | -US$268m |
Dec 31 2022 | US$3m | US$750k | -US$258m |
Sep 30 2022 | n/a | n/a | -US$157m |
Jun 30 2022 | n/a | n/a | -US$202m |
Mar 31 2022 | n/a | n/a | -US$223m |
Dec 31 2021 | US$3m | US$750k | -US$206m |
Sep 30 2021 | n/a | n/a | -US$164m |
Jun 30 2021 | n/a | n/a | -US$90m |
Mar 31 2021 | n/a | n/a | -US$57m |
Dec 31 2020 | US$2m | US$500k | -US$57m |
Sep 30 2020 | n/a | n/a | -US$52m |
Jun 30 2020 | n/a | n/a | -US$50m |
Mar 31 2020 | n/a | n/a | -US$72m |
Dec 31 2019 | US$750k | US$500k | -US$67m |
Sep 30 2019 | n/a | n/a | -US$57m |
Jun 30 2019 | n/a | n/a | -US$84m |
Mar 31 2019 | n/a | n/a | -US$64m |
Dec 31 2018 | US$2m | US$500k | -US$56m |
Sep 30 2018 | n/a | n/a | -US$40m |
Jun 30 2018 | n/a | n/a | -US$6m |
Mar 31 2018 | n/a | n/a | -US$3m |
Dec 31 2017 | US$94k | n/a | -US$3m |
Compensation vs Market: Boris's total compensation ($USD12.35M) is above average for companies of similar size in the Canadian market ($USD2.03M).
Compensation vs Earnings: Boris's compensation has increased whilst the company is unprofitable.
CEO
Boris Jordan (58 yo)
less than a year
Tenure
US$12,352,753
Compensation
Mr. Boris Alexis Jordan is Executive Chairman of the Board at Curaleaf, Inc. and serves as its CEO since 2024. He is Owner and Chief Investment Officer of Closed End Strategies of Measure 8 Ventures Manage...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | less than a year | US$12.35m | 17.37% CA$ 533.8m | |
Executive Vice-Chairman | 6.1yrs | US$1.23m | 0.71% CA$ 21.8m | |
Chief Financial Officer | 2.3yrs | US$2.76m | 0.033% CA$ 1.0m | |
Chief Legal Officer | 4.7yrs | US$1.39m | 0.11% CA$ 3.3m | |
Special Advisor | less than a year | US$5.18m | 0.57% CA$ 17.6m | |
Chief Investment Officer | 2.3yrs | no data | no data | |
Chief Accounting Officer | less than a year | no data | no data | |
Manager of Investor Relations | no data | no data | no data | |
Chief Compliance Officer | 4.7yrs | no data | no data | |
Executive Vice President of Marketing | 3.8yrs | no data | no data |
2.3yrs
Average Tenure
56yo
Average Age
Experienced Management: CURA's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 6.1yrs | US$12.35m | 17.37% CA$ 533.8m | |
Executive Vice-Chairman | 6.1yrs | US$1.23m | 0.71% CA$ 21.8m | |
Director | 4.3yrs | US$250.00k | 0.046% CA$ 1.4m | |
Independent Director | 6.1yrs | US$350.00k | 0.075% CA$ 2.3m | |
Independent Director | 6.1yrs | US$350.00k | 0.019% CA$ 581.7k | |
Member of the Medical Advisory Board | no data | no data | no data | |
Independent Director | 4.8yrs | US$250.00k | 0.74% CA$ 22.9m | |
Director | 1.9yrs | US$250.00k | 0.039% CA$ 1.2m | |
Independent Director | 1.9yrs | US$250.00k | 0.0089% CA$ 272.9k |
5.4yrs
Average Tenure
60.5yo
Average Age
Experienced Board: CURA's board of directors are considered experienced (5.4 years average tenure).